The thorax was the most common primary tumor site (n = 59, 40.0%), encompassing both thoracic SMARCA4-deficient undifferentiated tumors (SMARCA4-UT) and SMARCA4-altered non-small cell lung cancers (NSCLC). This evidence concerns the gene SMARCA4 and non-small cell lung carcinoma.